Monsanto Company (NYSE:MON) will release Q3 ’17 earnings before the market opens on Wednesday, June 28. Estimize and Wall Street are forecasting both earnings and revenue to come in lower than the previous quarter. The Estimize community is more bullish in comparison to the Street for EPS, estimating $1.88 vs. $1.74 for Wall Street. Switching to revenue, we see that the Street is roughly in line with Estimize, hovering around $4.1M. Last quarter we saw a big beat for Monsanto, which posted an EPS of $3.19, beating the Street by 43 cents.
Monsanto owns 34 different types of seeds and farming chemicals used to protect various crops.It is also on the cusp of becoming the largest supplier of both seeds and crop chemicals if the acquisition by Bayer (DE:BAYGN) is approved. Furthermore, the EPA just approved MON's bid to market its new insecticide, RNAi, with the intention of preventing western corn farmers from becoming victims of the “billion dollar pest,” otherwise known as the soybean cyst nematode. Based on these factors, Monsanto appears to be tightening its grasp on the agricultural market. Estimize’s data highlights that Monsanto shows positive price movement 57% of the time in the 1 to 5 days, post-earnings.
What are you expecting for MON?